LUNGLIFE AI INC. DL-,0001
Share · USU5500L1045 · A3CY3X (XLON)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LUNGLIFE AI INC. DL-,0001
No Price
Company Profile for LUNGLIFE AI INC. DL-,0001 Share
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
Company Data
Name LUNGLIFE AI INC. DL-,0001
Company LungLife AI, Inc.
Website
https://www.lunglifeai.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3CY3X
ISIN USU5500L1045
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Paul Pagano
Country United States of America
Currency EUR
Employees 0,0 T
Address 2545 West Hillcrest Drive, 91320 Thousand Oaks
IPO Date 2021-07-08
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | 9H4.F |
| London | LLAI.L |
More Shares
Investors who hold LUNGLIFE AI INC. DL-,0001 also have the following shares in their portfolio:
